Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics

The present study aims at comparing the change in cytokine levels in schizophrenia patients treated with atypical antipsychotics, with or without metabolic syndrome (MetS). The study included 101 patients with schizophrenia, 38 with and 63 without MetS, who received risperidone, quetiapine, olanzapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Gerasimova, Valeria I., Kornetov, Alexander N., Loonen, Anton J. M., Bokhan, Nikolay A., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150759/
https://www.ncbi.nlm.nih.gov/pubmed/34065135
http://dx.doi.org/10.3390/ph14050446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150759/
https://www.ncbi.nlm.nih.gov/pubmed/34065135
http://dx.doi.org/10.3390/ph14050446

Ejemplares similares